Evista contains 60 mg of raloxifene hydrochloride per tablet. It is used to treat and prevent osteoporosis in postmenopausal women, reducing the risk of vertebral fractures./Description: Evista is a prescription medication containing raloxifene hydrochloride, a selective estrogen receptor modulator (SERM). It mimics estrogen's beneficial effects on bone density, making it effective in treating and preventing osteoporosis in postmenopausal women. By increasing bone mineral density, Evista helps reduce the risk of vertebral fractures. Additionally, it has been shown to lower the risk of invasive breast cancer in certain populations. Unlike estrogen, Evista does not stimulate breast or uterine tissues, minimizing associated risks. Each tablet provides 60 mg of raloxifene hydrochloride, equivalent to 56 mg of raloxifene free base.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
